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ABSTRACT
Background: The association between daily walking and pneumonia mortality, stratiﬁed by the presence of disease conditions,
such as myocardial infarction (MI) or stroke, was investigated.
Methods: The study participants were 22,280 Japanese individuals (9,067 men and 13,213 women) aged 65–79 years. Inverse
propensity weighted competing risk model was used to calculate the hazard ratio (HR) and 95% conﬁdence interval (CI) for
pneumonia mortality.
Results: After a median of 11.9 years of follow-up, 1,203 participants died of pneumonia. Participants who did not have a history
of MI or stroke and who walked for 1 hour=day or more were less likely to die from pneumonia (HR 0.90; 95% CI, 0.82–0.98)
than those walked for 0.5 hours=day. A similar inverse association of pneumonia and walking (0.5 hours=day) was observed
among participants with a history of MI (HR 0.66; 95% CI, 0.48–0.90). Among the participants with a history of stroke, those
who walked for 0.6–0.9 hours=day were less likely to die because of pneumonia (HR 0.65; 95% CI, 0.43–0.98).
Conclusions: Regular walking for ≥1 hour=day may reduce the risk of pneumonia mortality in elderly individuals with or
without cardiovascular disease history.
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BACKGROUND
Pneumonia is one of the leading causes of death in developed
countries ranking sixth and eight in England1 and North
America,2 respectively, among all underlying causes of death.
Similarly, the combination of pneumonia and inﬂuenza ranks
third among the leading causes of death in the Japanese elderly
population, accounting for more than 561 deaths per 100,000
population annually.3 Indeed, several systematic reviews
suggested that age ≥65 years is a risk factor of pneumonia.4–6
Previous cohort studies showed that walking7 or high-intensity
physical activities8,9 were associated with a decreased risk of
pneumonia. However, the elderly population often has underlying
chronic diseases, such as myocardial infarction (MI) or stroke,
which may prevent them from walking and increase the risk of
pneumonia,10,11 and the association of walking with pneumonia
may result from a combination of underlying conditions.
Therefore, this study aimed to investigate whether daily walking
time was associated with pneumonia mortality in Japanese
participants aged 65–79 years with or without a medical history
of MI or stroke.
METHODS
Study population and data collection
The Japan Collaborative Cohort Study for Evaluation of Cancer
Risk (JACC Study), which was established in 1988–1990,
has been described in detail elsewhere.12,13 Brieﬂy, 110,585
inhabitants (46,395 men and 64,190 women) aged 40–79 years
from 45 areas in Japan were enrolled into the study. In the present
study, the overall number of baseline participants (aged 65–79
years) was 29,956 (12,196 men and 17,760 women). Data were
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collected through a self-administered questionnaire, and a
response rate of 83% was observed. Information on the average
number of daily walking hours and other lifestyle factors was
obtained from the baseline questionnaire. Participants were asked
about the average daily time spent walking: “How long on
average do you spend walking indoors or outside on a daily
basis?”, and the possible responses were: “<0.5 hours=day”, “0.5
hours=day,” “0.6–0.9 hours=day,” and “≥1.0 hours=day.”
Of the original cohort members, 5,492 participants in six areas
were excluded because the questionnaire that was used did not
include data on the average number of daily walking hours.
Furthermore, 2,184 participants from other areas with missing
data on the average daily walking hours were excluded.
Consequently, 22,280 participants (9,067 men and 13,213
women) were included in the present study.
Follow-up
The date and cause of death were conﬁrmed via death certiﬁcates
and coded according to the International Classiﬁcation of
Diseases, 10th Revision (ICD-10). The primary outcome of the
present study was death due to pneumonia or inﬂuenza (J9–18,
J69). Participants who moved away from the study area during
the study period were treated as censored cases.
Statistical analysis
We used four statistical models to calculate multivariate-
adjusted hazard ratios (HRs) and conﬁdence intervals (CIs) for
pneumonia-related mortality.14,15 First, we conducted multivariate
adjustment using an inverse probability weighting (IPW) method
based on generalized propensity scores because of a relatively
small number of pneumonia deaths.16 This approach is a
statistical alternative to propensity score matching that balances
the confounders in non-randomized studies. To develop the
generalized propensity score, we conducted a multinomial
logistic regression analysis for the four walking categories
using all the demographic information,17 including, age (as a
continuous variable), sex (male or female), smoking status (never,
former, current smoking, or unknown), alcohol drinking status
(never, former, current alcohol drinker, or unknown), body mass
index (BMI; <18.5, 18.5–24.9, ≥25.0 kg=m2, or unknown),
educational level (school age up to age 15 years, 15–18 years,
≥19 years, or unknown), marital status (single, married,
divorced=widowed, or unknown), depressive tendency (deﬁned
later; presence, absence, or unknown), sleep duration (<6.5
hours=day, 6.5–8.4 hours=day, ≥8.5 hours=day, or unknown),
and a history of cancer (yes or no=unknown), diabetes mellitus
(yes or no=unknown), kidney diseases (yes or no=unknown), and
asthma (yes or no=unknown). Four psychological or behavioral
items from the baseline questionnaire were used to quantify
depressive tendency.18 These items are the following: “Do you
think your life is meaningful?”, “Do you think you make
decisions quickly?”, “Are you enjoying your life?”, and “Do you
feel others rely very much on you?”. Participants with two or
more psychological or behavioral items were considered to have
a depressive tendency. Second, to assess for covariate balance,
we showed the propensity score overlap through kernel density
plots. Third, we then used an IPW Cox proportional hazards
model.19 Finally, we utilized a competing risk model,20 in which
death caused by factors other than pneumonia was considered as
a competing risk. Linear trends in mortality risks were assessed
based on four categories of walking hours per day, which were
used as numeric variables. To avoid an inverse causal relation-
ship, we considered the participants who walked for 0.5 hours=
day as ambulatory,21 and they were included in the reference
group. All statistical analyses were conducted separately among
participants with or without a history of MI or stroke. An alpha
level of 0.05 was considered statistically signiﬁcant. All statistical
analyses were performed using SAS 9.4 (SAS Institute Inc., Cary,
NC, USA). The graphs were drawn using JMP 12.0.2 (SAS
Institute Inc.).
RESULTS
Of the 22,280 participants, 1,210, 604, and 80 participants had
a history of MI, stroke, and both MI and stroke, respectively.
The baseline mean age of the participants was 70.5 (standard
deviation [SD], 4.1) years (men, 70.6 [SD, 4.1] years; women,
70.4 [SD, 4.1] years).
The baseline characteristics of the participants with or without a
history of MI or stroke according to daily walking time are shown
in Table 1. About 50.4% of participants without a history of MI
and stroke, 41.8% of participants with a history of MI, and 33.9%
of the participants with a history of stroke walked >1 hour daily.
Among the participants with or without a history of MI or stroke,
those who walked >1 hour=day were younger in age, women,
and current drinkers; these participants also had a BMI of 18.5–
25.0 kg=m2 and sleep duration of 6.5–8.4 hours=day. Moreover,
they were less likely to study in college or obtain a diploma
and have a depressive tendency and history of diabetes mellitus
and cancer compared with those who walked for 0.5 hours=day.
The diﬀerences of all the potential confounders among the four
categories of walking were reduced after weighting (eFigure 1).
The median follow-up period was 11.9 years. For 306,578
person-years of follow-up (109,078 person-years for men and
197,500 person-years for women), 1,203 participants (731 men
and 472 women) died from pneumonia, 1,367 left the study area,
and 9,753 died because of factors other than pneumonia. The HRs
of pneumonia mortality according to walking time are shown
in Table 2. Participants without a history of MI or stroke who
walked for more than 1 hour=day were less likely to die because
of pneumonia (HR 0.90; 95% CI, 0.82–0.98; P for trend < 0.001)
compared with those who walked for 0.5 hours=day. Similarly,
decreased HRs were observed among participants with a history
of MI (HR 0.66; 95% CI, 0.48–0.90; P for trend = 0.02). Among
the participants with a history of stroke, those who walked for
more than 0.6–0.9 hours=day were less likely to die because of
pneumonia compared with those who walked for 0.5 hour=day
(HR 0.65; 95% CI, 0.43–0.98). In contrast, the death of
individuals who walked ≥1 hour=day was not associated with
pneumonia (HR 1.15; 95% CI, 0.81–1.63).
DISCUSSION
In this large cohort study, participants without a history of MI or
stroke who walked for ≥1 hour=day were less likely to die from
pneumonia than those who walked for 0.5 hours=day. Similar
results were obtained among participants with a history of MI.
For participants with a history of stroke, those who walked for
0.6–0.9 hours=day were less likely to die from pneumonia than
those who walked for 0.5 hours=day. However, this inverse
association was not observed in participants with a history of
stroke who walked ≥1 hour=day.
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Participants with or without a history of MI or stroke who walk
for a longer number of hours per day were less likely to die from
pneumonia compared with those who walk for a shorter number
of hours per day. Our ﬁnding shows a reduced incidence of
pneumonia8 and pneumonia mortality7,9 in community residents
with moderate physical activities, and this ﬁnding is similar to
the results obtained from three previous studies. Whether elderly
individuals with coronary heart disease are more susceptible to
pneumonia than those without coronary heart disease is not
clear.22 Two studies, including a cohort study23 and nested case-
control study,10 suggested that elderly individuals with chronic
cardiovascular disease were more likely to develop pneumonia
compared with those without the disease condition (HR 1.46;
95% CI, 1.16–1.84 and HR 1.68; 95% CI, 1.58–1.77,
respectively). These individuals may acquire pneumonia because
of deteriorated immunological responses.24 Furthermore, since
pneumonia itself causes cardiac problems,25 such as left
ventricular dysfunction26,27 or increased cardiac arrhythmias,28,29
those who experienced cardiac complications along with
pneumonia were more likely to die.30 Therefore, walking may
be important for individuals with heart disease because it
enhances mucosal immune function in elderly individuals.31
Furthermore, moderate physical activities, such as walking,
enhance the immune function by increasing the activities of
macrophages, natural killer cells,32 and neutrophils and regulating
cytokines.33,34 However, caution must be taken into consider-
ation. Although rare, some patients with coronary artery disease
have sudden cardiac death during exercise, particularly habitually
sedentary adults.35 Thus, elderly individuals with a history of
coronary artery disease should obtain an exercise prescription
from physicians to avoid inappropriate physical activities.
A population-based cohort study suggested that elderly
participants with a history of stroke were 1.26 (95% CI,
1.08–1.48) times more likely to be diagnosed with pneumonia
than those without stroke after a 3-year follow-up.11 In the present
study, participants with a history of stroke who walked for
0.6–0.9 hours=day were less likely to die from pneumonia
compared with those who walked for 0.5 hours=day. This beneﬁt
was not observed among those who walked ≥1 hour=day.
However, the mechanisms explaining why a longer walking time
had no additional beneﬁts for elderly individuals with stroke was
unclear. Although a meta-analysis revealed that aerobic exercise
training during the chronic stage of stroke recovery has beneﬁcial
eﬀects on cardiorespiratory health,36 the oxygen cost of walking
among people with history of stroke is 2-fold higher than that
reported for non-stroke participants.37 Furthermore, other bio-
logical changes that may negatively aﬀect cardiorespiratory
health after stroke include elevated systemic levels of proin-
ﬂammatory markers, abnormal glucose levels and insulin
metabolism, impaired autonomic control, and respiratory
dysfunction.38 In the context of age- and disease-related
heterogeneity in cardiorespiratory capacity and medical comor-
bidities, walking duration ≥1 hour=day might be too much for
elderly individuals with a history of stroke. However, to clarify an
appropriate duration and time of physical activities for elderly
Table 2. Hazard ratios of pneumonia mortality according to
walking time among participants with/without a history
of MI or stroke
Walking time, hours=day PY n HR (95% CI)a HR (95% CI)b
Without history of MI and stroke
<0.5 22,288 141 1.44 (1.15, 1.81)+ 1.33 (1.22, 1.43)+
0.5 46,800 208 Ref Ref
0.6–0.9 57,351 230 0.95 (0.78, 1.14) 0.97 (0.89, 1.05)
≥1 142,023 489 0.84 (0.71, 0.99)+ 0.90 (0.82, 0.98)+
P for linear trend <0.001 <0.001
With history of MI
<0.5 1,340 12 0.88 (0.40, 1.96) 0.93 (0.70, 1.23)
0.5 2,850 21 Ref Ref
0.6–0.9 3,030 20 0.81 (0.44, 1.50) 0.90 (0.68, 1.21)
≥1 5,991 27 0.55 (0.31, 0.99)+ 0.66 (0.48, 0.90)+
P for linear trend 0.18 0.02
With history of stroke
<0.5 1,011 21 2.05 (1.01, 4.20)+ 1.66 (1.19, 3.33)+
0.5 1,537 14 Ref Ref
0.6–0.9 1,456 8 0.57 (0.24, 1.38) 0.65 (0.43, 0.98)+
≥1 2,535 22 0.89 (0.43, 1.83) 1.15 (0.81, 1.63)
P for linear trend 0.006 0.008
CI, conﬁdence interval; CVD, cardiovascular disease; HR, hazard ratio; MI,
myocardial infarction; PY, person-year.
P for trend was calculated across the categories of walking time. The
generalized propensity scores were calculated by a multinomial logistic
regression analysis for the four walking categories using the demographic
information, including, age, sex, smoking status, alcohol drinking status,
body mass index, educational level, marital status, depressive tendency,
sleep duration, and a history of cancer, diabetes mellitus, kidney diseases,
and asthma.
+P < 0.05.
aCox proportional hazard model with inverse propensity weighting.
bCompeting risk model with inverse propensity weighting.
Table 1. Baseline characteristics of participants with/without history of MI or stroke according to daily walking time (hours/day)
Characteristics Category
Without history of MI and stroke With history of MI With history of stroke
<0.5
(n = 1,983)
0.5
(n = 3,753)
0.6–0.9
(n = 4,426)
≥1
(n = 10,314)
<0.5
(n = 145)
0.5
(n = 303)
0.6–0.9
(n = 303)
≥1
(n = 539)
<0.5
(n = 146)
0.5
(n = 166)
0.6–0.9
(n = 140)
≥1
(n = 232)
Age, years 70.7 ± 4.3 70.7 ± 4.2 70.5 ± 4.1 70.2 ± 4.0 71.2 ± 4.1 71.4 ± 4.1 71.4 ± 4.3 70.8 ± 4.3 71.8 ± 4.2 71.8 ± 4.3 71.1 ± 4.1 71.0 ± 3.5
Sex Male 43.2 39.8 39.5 39.8 45.5 41.6 42.9 41.2 62.3 54.2 60.7 61.6
Body mass index, kg=m2 <18.5 11.6 10.8 9.6 9.6 9.0 9.2 8.9 8.1 12.3 14.5 8.6 9.5
18.5–24.9 59.2 61.5 65.2 66.1 58.6 65.4 64.0 66.6 56.9 59.0 67.1 66.0
≥25.0 19.0 18.0 16.5 15.6 17.9 18.2 16.2 16.7 18.5 13.9 18.6 13.8
College education Yes 0.4 0.4 0.6 0.3 0.7 1.0 0.7 0.2 2.1 0.6 0 0
Current smoker Yes 20.7 19.2 18.1 19.8 24.1 17.8 14.9 16.0 19.2 15.7 14.3 19.4
Current alcohol drinker Yes 30.9 34.4 34.7 35.0 26.9 39.3 37.3 35.1 23.3 29.5 33.6 44.0
Sleep duration, hours=day 6.5–8.4 54.6 56.8 59.7 59.7 38.6 55.5 53.5 54.0 39.7 48.2 55.0 52.6
Depressive tendency Yes 12.8 7.1 6.4 5.6 15.9 8.3 7.6 6.7 33.6 19.3 10.0 12.5
History of
Diabetes mellitus Yes 7.3 8.5 7.0 5.4 15.2 16.2 12.5 9.1 14.4 14.5 7.9 11.2
Kidney disease Yes 3.8 4.7 4.9 4.3 10.3 11.2 8.6 8.7 6.2 10.2 7.9 6.5
Asthma Yes 1.8 1.3 0.9 0.8 0.7 1.3 1.9 0 2.1 0 0 0.9
Cancer Yes 2.8 2.5 2.7 1.8 4.8 5.9 4.3 3.5 3.4 7.2 2.1 4.7
MI, myocardial infarction.
Values are expressed as mean ± standard deviation or percentage.
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individuals with a history of stroke, further epidemiological
studies should be conducted.
The strengths of the present study include its prospective
cohort design, long follow-up period, and an inclusion of
participants from Japan. Several limitations should be discussed.
First, we obtained information on the daily walking time through
self-report, and that information was not validated. Therefore,
some misclassiﬁcations were possibly included in our results.39
The use of an accelerometer40 can provide more reliable results.
Second, the eﬀects of the residual confounding factors were not
completely excluded. Third, information on the duration and
severity of MI and stroke were not available. These conditions
may aﬀect walking ability, capacity, or habit. Fourth, we obtained
information retrospectively via medical histories; therefore, some
misclassiﬁcation could be included in our results.
Conclusion
This large-scale cohort study demonstrated that walking at least
≥1 hour=day reduced the risk of pneumonia mortality among
elderly individuals with or without a medical history of MI.
Our ﬁndings suggest that regular walking may be beneﬁcial
in reducing the risk of pneumonia mortality in the elderly
population.
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